Category: Z79 - Long term (current) drug therapy

 Chapter Notes

 Section Notes

 Z79

Long term (current) drug therapy

long term (current) drug use for prophylactic purposes

Code also any therapeutic drug level monitoring (Z51.81)

drug abuse and dependence (F11-F19)

drug use complicating pregnancy, childbirth, and the puerperium (O99.32-)

 Z79.0

Long term (current) use of anticoagulants and antithrombotics/antiplatelets

long term (current) use of aspirin (Z79.82)

 Z79.01

Long term (current) use of anticoagulants

 Z79.02

Long term (current) use of antithrombotics/antiplatelets

 Z79.1

Long term (current) use of non-steroidal anti-inflammatories (NSAID)

long term (current) use of aspirin (Z79.82)

 Z79.2

Long term (current) use of antibiotics

 Z79.3

Long term (current) use of hormonal contraceptives

Long term (current) use of birth control pill or patch

 Z79.4

Long term (current) use of insulin

long-term (current) use of injectable non-insulin antidiabetic drugs (Z79.85)

long term (current) use of oral antidiabetic drugs (Z79.84)

long term (current) use of oral hypoglycemic drugs (Z79.84)

 Z79.5

Long term (current) use of steroids

 Z79.51

Long term (current) use of inhaled steroids

 Z79.52

Long term (current) use of systemic steroids

 Z79.6

Long term (current) use of immunomodulators and immunosuppressants

long term (current) use of steroids (Z79.5-)

long term (current) use of agents affecting estrogen receptors and estrogen levels (Z79.81-)

 Z79.60

Long term (current) use of unspecified immunomodulators and immunosuppressants

 Z79.61

Long term (current) use of immunomodulator

Long term (current) use of apremilast

Long term (current) use of immunomodulatory imide drug

Long term (current) use of lenalidomide

Long term (current) use of pomalidomide

 Z79.62

Long term (current) use of immunosuppressant

 Z79.620

Long term (current) use of immunosuppressive biologic

Long term (current) use of adalimumab

Long term (current) use of etanercept

Long term (current) use of infliximab

Long term (current) use of monoclonal antibodies

 Z79.621

Long term (current) use of calcineurin inhibitor

Long term (current) use of cyclosporine

Long term (current) use of tacrolimus

 Z79.622

Long term (current) use of Janus kinase inhibitor

Long term (current) use of tofacitinib

 Z79.623

Long term (current) use of mammalian target of rapamycin (mTOR) inhibitor

Long term (current) use of sirolimus

 Z79.624

Long term (current) use of inhibitors of nucleotide synthesis

Long term (current) use of azathioprine

Long term (current) use omycophenolate

Long term (current) use of purine synthesis (IMDH) inhibitors

 Z79.63

Long term (current) use of chemotherapeutic agent

 Z79.630

Long term (current) use of alkylating agent

Long term (current) use of chlorambucil

Long term (current) use of cisplatin

Long term (current) use of cyclophosphamide

 Z79.631

Long term (current) use of antimetabolite agent

Long term (current) use of 5-fluorouracil

Long term (current) use of 6-mercaptopurine

Long term (current) use of cytarabine

Long term (current) use of methotrexate

 Z79.632

Long term (current) use of antitumor antibiotic

Long term (current) use of bleomycin

Long term (current) use of doxorubicin

Long term (current) use of mitomycin C

 Z79.633

Long term (current) use of mitotic inhibitor

Long term (current) use of paclitaxel

Long term (current) use of plant alkaloids

Long term (current) use of vinblastine

Long term (current) use of vincristine

 Z79.634

Long term (current) use of topoisomerase inhibitor

Long term (current) use of etoposide

Long term (current) use of irinotecan

Long term (current) use of topotecan

 Z79.64

Long term (current) use of myelosuppressive agent

Long term (current) use of hydroxyurea

 Z79.69

Long term (current) use of other immunomodulators and immunosuppressants

 Z79.8

Other long term (current) drug therapy

 Z79.81

Long term (current) use of agents affecting estrogen receptors and estrogen levels

Code first, if applicable:

malignant neoplasm of breast (C50.-)

malignant neoplasm of prostate (C61)

Use additional code, if applicable, to identify:

estrogen receptor positive status (Z17.0)

family history of breast cancer (Z80.3)

genetic susceptibility to malignant neoplasm (cancer) (Z15.0-)

personal history of breast cancer (Z85.3)

personal history of prostate cancer (Z85.46)

postmenopausal status (Z78.0)

hormone replacement therapy (Z79.890)

 Z79.810

Long term (current) use of selective estrogen receptor modulators (SERMs)

Long term (current) use of raloxifene (Evista)

Long term (current) use of tamoxifen (Nolvadex)

Long term (current) use of toremifene (Fareston)

 Z79.811

Long term (current) use of aromatase inhibitors

Long term (current) use of anastrozole (Arimidex)

Long term (current) use of exemestane (Aromasin)

Long term (current) use of letrozole (Femara)

 Z79.818

Long term (current) use of other agents affecting estrogen receptors and estrogen levels

Long term (current) use of estrogen receptor downregulators

Long term (current) use of fulvestrant (Faslodex)

Long term (current) use of gonadotropin-releasing hormone (GnRH) agonist

Long term (current) use of goserelin acetate (Zoladex)

Long term (current) use of leuprolide acetate (leuprorelin) (Lupron)

Long term (current) use of megestrol acetate (Megace)

 Z79.82

Long term (current) use of aspirin

 Z79.83

Long term (current) use of bisphosphonates

 Z79.84

Long term (current) use of oral hypoglycemic drugs

Long term (current) use of oral antidiabetic drugs

long-term (current) use of injectable non-insulin antidiabetic drugs (Z79.85)

long term (current) use of insulin (Z79.4)

 Z79.85

Long-term (current) use of injectable non-insulin antidiabetic drugs

long term (current) use of insulin (Z79.4)

long term (current) use of oral hypoglycemic drugs (Z79.84)

 Z79.89

Other long term (current) drug therapy

 Z79.890

Hormone replacement therapy

 Z79.891

Long term (current) use of opiate analgesic

Long term (current) use of methadone for pain management

methodone use NOS (F11.9-)

use of methodone for treatment of heroin addiction (F11.2-)

 Z79.899

Other long term (current) drug therapy